Bad news for top-selling anemia drugs
16th Nov 2006, 14:50 GMT
A new medical study suggests that high doses of a best- selling drug used to treat anemia in dialysis and cancer patients may increase the risk of heart problems and death.
Latest news from Business - International Herald Tribune:
- IBM plans to join bid for Guangdong bank
- Deutsche Telekom readies for change of guard
- Venture firms bank on Pelosi to relax Sarbanes-Oxley rules
- U.S. pushes China on surplus
- Sun offers its Java free on Internet
- U.S. radio company may sell for $18 billion
- Slower rise in cost of food helps ease inflation in China
- Hitachi-GE alliance set to expand nuclear work
- Banking matters: Women and profit
- KB Home ousts chief for stock option deal